The challenge
Margins were under pressure from payer mix shifts and rising input costs. Previous cost-cutting exercises had compromised patient experience.
Our approach
We ran a zero-based cost diagnostic across clinical and non-clinical functions, redesigned procurement, optimized rosters with demand-led scheduling and digitized revenue-cycle management.
The outcome
Recurring annual EBITDA uplift of ₹95 Cr, OT utilization improved from 62% to 78%, and patient NPS rose by 9 points.